Table 2.
Likelihood that clinicians reported referring patients to clinical genetic services or ordering tumour analysis in the past 12 months, by provider group a,b.
| Total (N = 144) | GP (N = 18) | GYN (N = 24) | GE (N = 11) | ONC (N = 59) | SURG (N = 27) | Others c (N = 5) | |
|---|---|---|---|---|---|---|---|
| N(%; 95%CI) d | N(%;95%CI) d p-value | N(%;95%CI) d p-value | N(%;95%CI) d p-value | N(%;95%CI) d p-value | N(%;95%CI)d p-value | N(%;95%CI) d p-value | |
| Referred patients to genetic services | 112 (78; 70–84) | 9 (50; 29–71) 0.003 | 19 (79; 60–91) 0.969 | 10 (91; 62–98) 0.458 | 50 (85; 73–92) 0.095 | 22 (81; 63–92) 0.799 | 2 (50) 0.196 |
| Ordered tumour IHC testing | 77 (53; 45–61) | 4 (22; 9–45) 0.002 | 6 (25; 12–45) 0.003 | 8 (73; 43–90) 0.524 | 39 (66; 53–77) 0.030 | 20 (74; 55–87) 0.004 | 0 - |
| Ordered tumour MSI testing | 55 (38; 31–46) | 1 (6; 1–26) 0.002 | 3 (13; 4–31) 0.004 | 6 (55; 28–79) 0.527 | 29 (49; 37–62) 0.075 | 16 (59; 41–75) 0.005 | 0 - |
| Ordered DNA mutation testing | 67 (47; 39–55) | 6 (33; 16–56) 0.125 | 7 (29; 15–49) 0.034 | 3 (27; 10–57) 0.308 | 36 (61; 48–72) 0.007 | 15 (56; 37–72) 0.249 | 0 - |
Abbreviations: GP general practitioners; GYN gynaecologists; GE gastroenterologists; ONC oncologists; SURG surgeons; CI confidence interval; IHC immunohistochemistry; MSI microsatellite instability. a Category totals may be less than the total number of respondents due to missing values; b Bolded estimates indicate significant findings; c Other medical specialties include cancer care coordinator (n = 1), genetic counsellor (n = 1), psycho-oncologists (n = 2), social worker (n = 1); d The % reflects the percentage responding within each practice category.